Image
18.11.2021
Dapagliflozin (Forxiga) is no longer to be used for type 1 diabetes
AstraZeneca has announced that the medication Dapagliflozin (Forxiga) will no longer be licensed for use ...
From research findings showing a step forward for beta cell therapy without immunosuppression in type 1 diabetes, to a triple hormone drug that shows promise to treat type 2, here are some of the diabetes research developments announced in March 2026.
Read more